We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.
Therapeutics (in Vivo)
Antibodies for Assays
If registering with this site, this screen allows you to choose your password. If you forgot your password, this screen allows you to reset. Once you enter your password, please use the Sign-In link at the top of the page to login to the site.
The email will contain a link. Click the link to go to a page where you will be able to reset your password to a new one.
Partner With Us
Our anti-IL-10 was used to neutralize cytokines in vivo during Mycobacterium tuberculosis infection.
Check it out on J. Immunol. 204: 644–659. https://t.co/b3pxFv4IF2?amp=1
Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!
Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.
Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!
Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.
Now you can directly contribute your experimental data to our reactivity datatase. Send us your beautiful graphs and figures!
Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.
We have species-specific reagents for preclinical studies in monkeys. Reach us if you are interested in learning about reagent partnerships.
We continue to grow the publication database so that peer-reviewed results can inform future research decisions.
The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).
Copyright © 2004-2021